Clinical, hormonal and metabolic studies in patients undergoing second trimester abortion with prostaglndin F2 alpha, 15(S)-15-methyl0PGF2 alpha and hypertonic saline.
D000019:Abortifacient Agents / Q000627:therapeutic use*; D000650:Amnion; D005260:Female; D006801:Humans; D007267:Injections; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011460:Prostaglandins F / Q000627:therapeutic use*; D012462:Saline Solution, Hypertonic / Q000627:therapeutic use*; D012965:Sodium Chloride / Q000627:therapeutic use*; D013997:Time Factors
D000019:Abortifacient Agents; D011460:Prostaglandins F; D012462:Saline Solution, Hypertonic; D012965:Sodium Chloride